Verastem (VSTM) Crumbles: Stock Falls by 6.1%

Zacks Equity Research
0

Verastem, Inc. (VSTM) saw a big move last session, as the company’s shares fell by over 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for VSTM, as the stock is now down 14.8% in the past one-month time frame.

The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks (no increase, no decrease), and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

VSTM currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Investors interested in the pharmaceutical industry may consider better-ranked stocks like Biogen Idec Inc. (BIIB), Curis, Inc. (CRIS) and Epizyme, Inc. (EPZM). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



VERASTEM INC (VSTM): Free Stock Analysis Report


Zacks Investment Research

Advertisement

Recommended Stories